Quantcast

Latest Gene therapy Stories

2014-08-14 16:26:36

GREENWICH, Conn., Aug. 14, 2014 /PRNewswire/ -- Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications, today announced the sale of its lentiviral vector manufacturing business and related assets to Miltenyi Biotec, who will operate through its newly formed, wholly-owned US subsidiary Lentigen Technology, Inc. based in Gaithersburg, MD. In connection with the transaction, Lentigen Corporation has been renamed Opus Bio, Inc., and has been...

2014-08-14 16:26:34

BERGISCH GLADBACH, Germany, August 14, 2014 /PRNewswire/ -- Addition of lentiviral gene delivery capabilities complements strategic partnering portfolio. Miltenyi Biotec announced today that it has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications. The acquisition further strengthens Miltenyi Biotec's portfolio in cell and...

2014-08-13 08:26:49

SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is "highly warranted" to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional...

2014-08-11 23:01:33

Darst and Landes – both of whom lost mothers to cancer – will connect with a younger demographic. Stamford, CT (PRWEB) August 11, 2014 Alliance for Cancer Gene Therapy, Inc. (ACGT) – the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer – has announced that David Darst and Alexandra Landes have joined the foundation’s Board of Directors. Both Darst and Landes lost their mothers to cancer and share a commitment to uncovering innovative methods...

2014-08-11 16:28:00

Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious Diseases Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, WA, Aug. 11, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately...

2014-07-21 08:29:00

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to...

2014-07-10 12:45:13

Salk Institute New results ease previous concerns that gene-editing techniques—used to develop therapies for genetic diseases—could add unwanted mutations to stem cells. The ability to switch out one gene for another in a line of living stem cells has only crossed from science fiction to reality within this decade. As with any new technology, it brings with it both promise—the hope of fixing disease-causing genes in humans, for example—as well as questions and safety concerns....

2014-07-07 12:28:59

Engineered Cells Known As CTL019 Are the First Therapy of Their Kind to Obtain Designation PHILADELPHIA, July 7, 2014 /PRNewswire/ -- A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL). The investigational therapy, known as CTL019, is the first personalized cellular therapy for the...

2014-06-25 23:00:47

Eighth annual Greenwich-Stamford Open Water Swim unites Connecticut residents to find a cure. Stamford, CT (PRWEB) June 25, 2014 Over 300 volunteers from across Connecticut and beyond came together on Saturday, June 21 at the eighth-annual Greenwich-Stamford Swim Across America event, raising over $300,000 to benefit Stamford’s Alliance for Cancer Gene Therapy (ACGT) in the fight against cancer. Participants spent the morning swimming half-mile, 1.5-mile or three-mile courses in the...

2014-06-24 08:32:14

Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx(®) Ad5FGF-4, Cardium Therapeutics' angiogenic gene...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.